Reconstitution Reconstituting copper peptides requires bacteriostatic water and sterile technique
Most community protocols start cagrilintide at 0.25 mg/week once retatrutide is established, then step up every 4 weeks to 0.5, 1.0, 1.7, and 2.4 mg/week
systemic diseases (e.g., cancer, diabetes, heart disease, recent myocardial infarction within 6 months, recent symptoms of angina pectoris, or congenital heart disease)
Our commitment to providing high-quality All Peptides supports this long-term vision
Read our complete GHK-Cu research guide for comprehensive background, or explore our complete peptide research guide for broader context